It looks like your browser is outdated. For the best experience, please consider updating to the latest version or switching to another browser (Firefox, Chrome, Safari).

Skip Navigation

A commitment to investors

We are committed to working on your behalf to build long-term shareholder value in pursuit of our mission.


All information available through the links on this page is current only as of the date on which it was presented, and Baxter does not undertake to update any statements included therein except as updated through subsequent communications.

2015 Investor Conference - Baxalta
Ludwig Hantson, Ph.D.Baxalta Overview
Bob HombachFinancial Overview
John Orloff, M.D.Innovation
Brian GoffHematology
Ron LloydImmunology
David MeekOncology
Supplemental Financial SchedulesSupplemental Financial Schedules
2015 Investor Conference - Baxter
Bob ParkinsonBaxter Overview
Jay SaccaroFinancial Overview
Jill SchaafRenal Overview
Brik EyreHospital Products Overview
Paul VibertInternational Overview
Marcus Shabacker M.D.,Ph.D.R&D Overview
Non-GAAP Reconciliation as of May 18,2015Non-GAAP Reconciliation as of May 18,2015
There are currently no items available.